![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LINC00909 |
Gene summary for LINC00909 |
![]() |
Gene information | Species | Human | Gene symbol | LINC00909 | Gene ID | 400657 |
Gene name | ZNF407 antisense RNA 1 | |
Gene Alias | LINC00909 | |
Cytomap | 18q22.3 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
400657 | LINC00909 | P76T-E | Human | Esophagus | ESCC | 1.78e-14 | 2.27e-01 | 0.1207 |
400657 | LINC00909 | P79T-E | Human | Esophagus | ESCC | 2.27e-21 | 3.63e-01 | 0.1154 |
400657 | LINC00909 | P80T-E | Human | Esophagus | ESCC | 1.74e-07 | 2.06e-01 | 0.155 |
400657 | LINC00909 | P82T-E | Human | Esophagus | ESCC | 4.14e-03 | 1.93e-01 | 0.1072 |
400657 | LINC00909 | P83T-E | Human | Esophagus | ESCC | 7.68e-17 | 3.71e-01 | 0.1738 |
400657 | LINC00909 | P89T-E | Human | Esophagus | ESCC | 6.19e-09 | 3.79e-01 | 0.1752 |
400657 | LINC00909 | P91T-E | Human | Esophagus | ESCC | 8.74e-05 | 4.65e-01 | 0.1828 |
400657 | LINC00909 | P107T-E | Human | Esophagus | ESCC | 3.84e-08 | 1.80e-01 | 0.171 |
400657 | LINC00909 | P127T-E | Human | Esophagus | ESCC | 3.66e-04 | 9.86e-02 | 0.0826 |
400657 | LINC00909 | P128T-E | Human | Esophagus | ESCC | 1.37e-04 | 1.45e-01 | 0.1241 |
400657 | LINC00909 | P130T-E | Human | Esophagus | ESCC | 9.35e-10 | 1.82e-01 | 0.1676 |
400657 | LINC00909 | HCC1_Meng | Human | Liver | HCC | 1.26e-15 | 8.28e-04 | 0.0246 |
400657 | LINC00909 | HCC2 | Human | Liver | HCC | 1.39e-11 | 1.77e+00 | 0.5341 |
400657 | LINC00909 | HCC5 | Human | Liver | HCC | 2.29e-17 | 1.56e+00 | 0.4932 |
400657 | LINC00909 | S028 | Human | Liver | HCC | 2.01e-02 | 2.49e-01 | 0.2503 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |